Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis

Osteoarthritis and Cartilage

Volumn 16, Issue 7, 2008, Pages 749-755

  Monfort, J ^a   Tardif, G ^b   Roughley, P ^c   Reboul, P ^b   Boileau, C ^b   Bishop, P N ^d   Pelletier, J P ^b   Martel Pelletier, J ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NOTRE DAME HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

MMP 13; Opticin; Osteoarthritis; SLRP

Indexed keywords

COLLAGENASE 3; GLYCOPROTEIN; GUANIDINE; MESSENGER RNA; OPTICIN; PROTEOGLYCAN; SMALL LEUCINE RICH REPEAT PROTEOGLYCAN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; BONE PLATE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; OSTEOBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN TARGETING; PROTEOGLYCAN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SYNOVIUM; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; CARTILAGE, ARTICULAR; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HUMANS; KNEE JOINT; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 45449087754     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.11.007     Document Type: Article

References (43)

1. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 (1998) 778-799
2. Heinegard D., Bayliss M., and Lorenzo P. Pathogenesis of structural changes in the osteoarthritic joint. In: Brandt K.D., Doherty M., and Lohmander S.L. (Eds). Osteoarthritis. 2nd edn. (2003), Oxford University Press Inc., New York 73-92
3. Huxley-Jones J., Robertson D.L., and Boot-Handford R.P. On the origins of the extracellular matrix in vertebrates. Matrix Biol 26 (2007) 2-11
4. McEwan P.A., Scott P.G., Bishop P.N., and Bella J. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155 (2006) 294-305
5. Iozzo R.V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274 (1999) 18843-18846
6. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., and Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136 (1997) 729-743
7. Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., LaMantia C., and Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141 (1998) 1277-1286
8. Svensson L., Aszodi A., Reinholt F.P., Fassler R., Heinegard D., and Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274 (1999) 9636-9647
9. Reardon A.J., Le Goff M., Briggs M.D., McLeod D., Sheehan J.K., Thornton D.J., et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem 275 (2000) 2123-2129
10. Bishop P.N., Takanosu M., Le Goff M., and Mayne R. The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye 16 (2002) 454-460
11. Ramesh S., Bonshek R.E., and Bishop P.N. Immunolocalisation of opticin in the human eye. Br J Ophthalmol 88 (2004) 697-702
12. Takanosu M., Boyd T.C., Le Goff M., Henry S.P., Zhang Y., Bishop P.N., et al. Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene. Invest Ophthalmol Vis Sci 42 (2001) 2202-2210
13. Frolova E.I., Fokina V.M., and Beebe D.C. The expression pattern of opticin during chicken embryogenesis. Gene Expr Patterns 4 (2004) 335-338
14. Pellegrini B., Acland G.M., and Ray J. Cloning and characterization of opticin cDNA: evaluation as a candidate for canine oculo-skeletal dysplasia. Gene 282 (2002) 121-131
15. Le Goff M.M., Hindson V.J., Jowitt T.A., Scott P.G., and Bishop P.N. Characterization of opticin and evidence of stable dimerization in solution. J Biol Chem 278 (2003) 45280-45287
16. Bishop P.N. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 19 (2000) 323-344
17. Hindson V.J., Gallagher J.T., Halfter W., and Bishop P.N. Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis Sci 46 (2005) 4417-4423
18. Knudson C.B., and Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 12 (2001) 69-78
19. Magali M., Le Goff M.M., and Bishop P.N. Focus on molecules: Opticin. Exp Eye Res 85 (2007) 303-304
20. Sanders E.J., Walter M.A., Parker E., Aramburo C., and Harvey S. Opticin binds retinal growth hormone in the embryonic vitreous. Invest Ophthalmol Vis Sci 44 (2003) 5404-5409
21. Martel-Pelletier J., Welsch D.J., and Pelletier J.P. Metalloproteases and inhibitors in arthritic diseases. In: Woolf A.D. (Ed). Baillière's Best Practice & Research Clinical Rheumatology (2001), Baillière Tindall, East Sussex, United Kingdom 805-829
22. Tardif G., Reboul P., Pelletier J.P., and Martel-Pelletier J. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol 14 (2004) 197-204
23. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., and Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322 (1997) 809-814
24. Heathfield T.F., Onnerfjord P., Dahlberg L., and Heinegard D. Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem 279 (2004) 6286-6295
25. Li Y., Aoki T., Mori Y., Ahmad M., Miyamori H., Takino T., et al. Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 64 (2004) 7058-7064
26. Monfort J., Tardif G., Reboul P., Mineau F., Roughley P., Pelletier J.P., et al. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther 8 (2006) R26
27. Altman R.D., Asch E., Bloch D.A., Bole G., Borenstein D., Brandt K.D., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986) 1039-1049
28. Roughley P.J., White R.J., and Poole A.R. Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J 231 (1985) 129-138
29. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., and Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 97 (1996) 2011-2019
30. Massicotte F., Fernandes J.C., Martel-Pelletier J., Pelletier J.P., and Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 38 (2006) 333-341
31. Fernandes J.C., Martel-Pelletier J., Jovanovic D., Tardif G., Di Battista J.A., Lascau-Coman V., et al. Effects of tenidap on canine experimental osteoarthritis II: study of the expression of collagenase-1 and IL1β by in situ hybridization. J Rheumatol 25 (1998) 951-958
32. Farndale R.W., Sayers C.A., and Barrett A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9 (1982) 247-248
33. Tardif G., Hum D., Pelletier J.P., Boileau C., Ranger P., and Martel-Pelletier J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 50 (2004) 2521-2530
34. Martel-Pelletier J., Lajeunesse D., and Pelletier J.P. Etiopathogenesis of osteoarthritis. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis & Allied Conditions. A Textbook of Rheumatology. 15th edn. (2005), Lippincott, Williams & Wilkins, Baltimore 2199-2226
35. Fosang A.J., Last K., Knauper V., Murphy G., and Neame P.J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380 (1996) 17-20
36. Deng S.J., Bickett D.M., Mitchell J.L., Lambert M.H., Blackburn R.K., Carter III H.L., et al. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J Biol Chem 275 (2000) 31422-31427
37. Johansson N., Saarialho-Kere U., Airola K., Herva R., Nissinen L., Westermarck J., et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208 (1997) 387-397
38. Stahle-Backdahl M., Sandstedt B., Bruce K., Lindahl A., Jimenez M.G., Vega J.A., et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 76 (1997) 717-728
39. Fernandes J.C., Martel-Pelletier J., Lascau-Coman V., Moldovan F., Jovanovic D., Raynauld J.P., et al. Collagenase-1 and collagenase-3 synthesis in early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 25 (1998) 1585-1594
40. Moldovan F., Pelletier J.P., Hambor J., Cloutier J.M., and Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 40 (1997) 1653-1661
41. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., and Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46 (2002) 2648-2657
42. Aigner T., Zien A., Hanisch D., and Zimmer R. Gene expression in chondrocytes assessed with use of microarrays. J Bone Joint Surg Am 85-A Suppl 2 (2003) 117-123
43. Melching L.I., Fisher W.D., Lee E.R., Mort J.S., and Roughley P.J. The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage 14 (2006) 1147-1154